Latest Hematologic Podcast Episodes
Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
Hematologic Oncology Update - May 29, 2024 20:20 - 1 hour ★★★★★ - 67 ratingsDr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas.
Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Hematologic Oncology Update - May 28, 2024 19:17 - 33 minutes ★★★★★ - 67 ratingsDr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
Hematologic Oncology Update - May 24, 2024 16:31 - 42 minutes ★★★★★ - 67 ratingsDr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Hematologic Oncology Update - May 14, 2024 18:53 - 1 hour ★★★★★ - 67 ratingsDrs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease.
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
CCO Oncology Podcast - May 14, 2024 04:00 - 25 minutesIn this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the landmark EMERALD study that led to FDA approval of elacestrant, the first oral selective estrogen receptor degrader (SERD) for treatment of hormone ...
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
CCO Oncology Podcast - May 07, 2024 16:44 - 47 minutesIn this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share strategies for applying these recommendations in your clinical practice to optimize treatment and outcomes. The greater discussion addresses: Optimal...
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
Hematologic Oncology Update - May 02, 2024 19:13 - 1 hour ★★★★★ - 67 ratingsDr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis.
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
Hematologic Oncology Update - April 26, 2024 18:03 - 1 hour ★★★★★ - 67 ratingsDr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease.
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
Hematologic Oncology Update - April 24, 2024 18:15 - 1 hour ★★★★★ - 67 ratingsDr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera.
Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
Hematologic Oncology Update - April 12, 2024 21:00 - 1 hour ★★★★★ - 67 ratingsDr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome.
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
CCO Oncology Podcast - March 28, 2024 16:28 - 48 minutesIn this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to guide treatment decisions in advanced prostate cancer, with topics including: Rationale for targeting PARP in prostate cancer with ARI combinat...
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
Hematologic Oncology Update - March 27, 2024 16:12 - 1 hour ★★★★★ - 67 ratingsDr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma.
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
CCO Oncology Podcast - March 18, 2024 14:38 - 36 minutesIn this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for patients with unresectable or metastatic HER2-low, hormone receptor–positive, and triple-negative breast cancer, including: Challenges with the path...
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
Hematologic Oncology Update - March 08, 2024 17:45 - 1 hour ★★★★★ - 67 ratingsDr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
Hematologic Oncology Update - February 27, 2024 17:55 - 58 minutes ★★★★★ - 67 ratingsDr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia.
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
Hematologic Oncology Update - January 17, 2024 13:34 - 1 hour ★★★★★ - 67 ratingsDr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes.
Current Considerations for Adverse Event Management With HER3-Directed Agents
CCO Oncology Podcast - December 26, 2023 19:43 - 12 minutesThe third and final episode in a 3-part series covers the safety profile of and considerations for managing adverse events associated with HER3-targeted antibody–drug conjugates, including patritumab deruxtecan (HER3-DXd) and others, in the setting of lung cancer. Presenters in this series inc...
Unpacking the Potential of HER3-Targeted Therapy in NSCLC
CCO Oncology Podcast - December 26, 2023 19:43 - 15 minutesThis second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including: Recent data on patritumab deruxtecan (HER3-DXd) in the HERTHENA-Lung01 trial The EGFRxHER3 bispecific antibodies BL-B01D1 and izalontamab The HER2xHER3...
Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer
CCO Oncology Podcast - December 26, 2023 05:00 - 8 minutesThis first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs. Presenters in this series include: Rebecca S. Heist, MD, MPH Associate Professor of Medicine Harvard Medical School Medical Oncology Massachusett...
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
CCO Oncology Podcast - December 04, 2023 13:56 - 30 minutesIn this episode, Brian Slomovitz, MD, MS, FACOG, and Keiichi Fujiwara, MD, PhD, share their thoughts and opinions on seminal data presented at the 2023 IGCS annual meeting for endometrial, ovarian, and cervical cancers, including: Phase III NRG GY018 trial of carboplatin and paclitaxel with or ...
Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis
CCO Oncology Podcast - November 30, 2023 14:09 - 19 minutesIn this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis, including: Navitoclax (BCL-XL/BCL-2 inhibitor) Pelabresib (BET inhibitor) Imetelstat (telomerase inhibitor) Luspatercept (erythroid maturat...
A Year in Review and a Look to the Future: BTKi in CLL and MCL
CCO Oncology Podcast - November 20, 2023 05:00 - 27 minutesIn this episode, Ana Marin-Niebla, MD, PhD, and Stephan Stilgenbauer, MD, discuss key trial data on the use of BTK inhibitors in CLL and MCL throughout the past year, how these studies have impacted their practice, and what data they are looking forward to in the near future. The discussion incl...
Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
CCO Oncology Podcast - November 17, 2023 19:36 - 33 minutesIn this episode, Isabelle Ray-Coquard, MD, PhD, and Ana Oaknin, MD, PhD, provide expert insights on new clinical trial data presented at the 2023 ESMO annual congress for endometrial, ovarian, and cervical cancers, including: Results from the double-blind, randomized, placebo-controlled phase I...
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
Hematologic Oncology Update - November 10, 2023 22:36 - 1 hour ★★★★★ - 67 ratingsDr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes.
Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer
CCO Oncology Podcast - November 07, 2023 05:00 - 38 minutesIn this episode, Aakash Desai, MD; Narjust Florez, MD; and Paolo Tarantino, MD, discuss the biologic rationale and clinical development of agents targeting HER3 for the treatment of breast and lung cancers. The potential niche for HER3-targeted agents in these treatment landscapes is considered,...
Improving Care for Black Patients With Endometrial Cancer
CCO Oncology Podcast - November 06, 2023 17:21 - 26 minutesIn this episode, Dr Leslie Boyd and Adrienne Moore, a patient advocate and endometrial cancer survivor, discuss how healthcare professionals can partner with Black patients to improve the diagnosis and management of endometrial cancer (EC). Topics include: Data on racial disparities in EC survi...
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Hematologic Oncology Update - October 20, 2023 22:43 - 1 hour ★★★★★ - 67 ratingsDr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging optimal management approaches for patients with acute myeloid leukemia and myelodysplastic syndromes.
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
Hematologic Oncology Update - October 19, 2023 18:23 - 1 hour ★★★★★ - 67 ratingsDr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma.
Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
Hematologic Oncology Update - October 18, 2023 18:40 - 1 hour ★★★★★ - 67 ratingsDr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent updates and future directions in the management of newly diagnosed and relapsed/refractory multiple myeloma.
Expert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
CCO Oncology Podcast - October 13, 2023 04:00 - 24 minutesIn this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide expert insights on key updates and new clinical trial data presented at the ESGO 2023 Congress for cervical, endometrial, and ovarian cancers, including: Long-Term Follow Up From Phase III SIENDO Study of Selinexo...
Related Hematologic Topics
- Oncology 2